NLRP3 and peripheral neuropathy: Moreover, eicosapentaenoic acid alleviated the hyperalgesia in oxaliplatin-induced peripheral neuropathy mice by inhibiting NETs formation and then abolishing NLR family pyrin domain containing 3 (NLRP3) inflammasome activation [64].